Cetrorelix acetate
Cetrorelix acetate Basic information
- Product Name:
- Cetrorelix acetate
- Synonyms:
-
- AC-(D-ALA[3-(2-NAPHTHYL)])-[D-PHE(4-CL)]-(D-ALA[3-(3-PYRIDYL)])-SER-TYR-(D-CIT)-LEU-ARG-PRO-D-ALA-OH
- Cetrorelix acetate
- CETRORELIX
- CETRORELIX ACID
- CETRIZINEDIHYDROCHLORIDE
- N-Acetyl-3-(2-naphthalenyl)-D-Ala-4-chloro-D-Phe-3-(3-pyridyl)-D-Ala-L-Ser-L-Tyr-N5-(aminocarbonyl)-D-Orn-L-Leu-L-Arg-L-Pro-D-Ala-NH2
- Cetrorelixum
- Cetrorelixum [inn-latin]
- CAS:
- 120287-85-6
- MF:
- C70H92ClN17O14
- MW:
- 1431.04
- EINECS:
- 686-384-6
- Product Categories:
-
- Peptide
- GYL
- Mol File:
- 120287-85-6.mol
Cetrorelix acetate Chemical Properties
- Melting point:
- >259°C (dec.)
- Density
- 1.42±0.1 g/cm3(Predicted)
- storage temp.
- Refrigerator
- solubility
- DMSO (Slightly, Heated), Methanol (Very Slightly)
- form
- Solid
- pka
- 9.82±0.15(Predicted)
- color
- White to Off-White
- InChIKey
- SBNPWPIBESPSIF-MHWMIDJBSA-N
Safety Information
- Hazardous Substances Data
- 120287-85-6(Hazardous Substances Data)
Cetrorelix acetate Usage And Synthesis
Description
Cetrorelix was launched in Germany for the treatment of female infertility. It is a decapeptidic analog of luteinizing hormone-releasing hormone (LH-RH) bearing structural modifications in the crucial positions 1, 2, 3, 6 and 10 : [Ac-D-Nal1, D-4-CI Phe-2, D-Pal3, D-Cit6, D-Alal0]-GnRH. Cetrorelix is an extremely potent and long acting gonadotrophin releasing hormone (GnRH) antagonist and thus blocks gonadotrophins and sex steroid secretion immediately after administration. Moreover, it has a low histamine-releasing potency. Cetrorelix will be the first LH-RH antagonist approved worldwide. In several Phase III clinical trials, female patients receiving Cetrorelix had a successful controlled ovulation thus avoiding a premature LH-surge. Cetrorelix could be a first-choice in-vitro fertilization (IVF) treatment without the complications of current controlled ovarian hyperstimulation protocols. Cetrorelix is currently under clinical investigation for the treatment of diverse sex hormone dependent disorders such as benign prostate hypertrophy, breast, ovarian or prostate cancers and diverse gynaecological disorders.
Originator
Asta Medica (Germany)
Uses
Cetrorelix Acetate is an gonadotropin-releasing hormone antagonist and is used to treat hormone-sensitive cancers of the prostate and breast.
Definition
ChEBI: A synthetic ten-membered oligopeptide comprising N-acetyl-3-(naphthalen-2-yl)-D-alanyl, 4-chloro-D-phenylalanyl, 3-(pyridin-3-yl)-D-alanyl, L-seryl, L-t rosyl, N5-carbamoyl-D-ornithyl, L-leucyl, L-arginyl, L-prolyl, and D-alaninamide residues coupled in sequence. A gonadotrophin-releasing hormone (GnRH antagonist, it is used for treatment of infertility and of hormone-sensitive cancers of the prostate and breast.
brand name
Cetrotide (Serono).
Cetrorelix acetateSupplier
- Tel
- 0571-86297909 15268405618
- sisi.xiang@sinopep.com
- Tel
- 15295566865 15295566865
- glenn@synpeptide.com
- Tel
- 0571-86737118-8680 15988144796
- sales@chinesepeptide.com
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com